Survival of intraoperative massive pulmonary embolism using alteplase and VA-ECMO

J Clin Anesth. 2019 Nov:57:112. doi: 10.1016/j.jclinane.2019.03.007. Epub 2019 Apr 6.

Authors

Monica I Lupei¹, Benjamin Kloesel², Lida Trillos², Ioanna Apostolidou²

Affiliations

¹ Department of Anesthesiology, University of Minnesota, Minneapolis, MN, United States of America; VA Health Care System Minneapolis, MN, United States of America. Electronic address: lupei001@umn.edu.
² Department of Anesthesiology, University of Minnesota, Minneapolis, MN, United States of America; VA Health Care System Minneapolis, MN, United States of America.

PMID: 30965272
DOI: 10.1016/j.jclinane.2019.03.007

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Arthroplasty / adverse effects
Bone Neoplasms / surgery
Cardiopulmonary Resuscitation
Chondrosarcoma / surgery
Extracorporeal Membrane Oxygenation
Femur / surgery
Fibrinolytic Agents / administration & dosage*
Heart Arrest / diagnosis
Heart Arrest / etiology
Heart Arrest / therapy*
Humans
Intraoperative Complications / diagnosis
Intraoperative Complications / etiology
Intraoperative Complications / therapy*
Male
Middle Aged
Monitoring, Intraoperative
Pulmonary Embolism / diagnosis
Pulmonary Embolism / etiology
Pulmonary Embolism / therapy*
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / administration & dosage*
Treatment Outcome
Vasoconstrictor Agents / administration & dosage

Substances

Fibrinolytic Agents
Vasoconstrictor Agents
Tissue Plasminogen Activator